USSTOCK.TODAY
Weekend. Closed
Log in Sign up

Pelthos Therapeutics Announces 114% Increase in Zelsuvmi Sales and Acquisition of Castle Creek Biosciences

The Motley Fool +1 · ·by G4L

PTHS
PTHS Pelthos Therapeutics Inc
$7.44 -7.35%
View chart & analysis →
  1. 1Pelthos Therapeutics recorded a 114% year-over-year increase in Zelsuvmi net product sales in the third quarter of 2026.
  2. 2Pelthos Therapeutics announced a deal to acquire Castle Creek Biosciences on October 30.
  3. 3Pelthos Therapeutics recorded $15.2 million in Zelsuvmi net sales in the third quarter of 2026.

So what's the key point?

Sales of Pelthos Therapeutics' drug increased by 114 percent compared to last year. The company is looking to expand its business by acquiring another company.

Source The Motley Fool +1 · View original ↗

Related 3-line summaries

Pelthos Therapeutics and Castle Creek Biosciences pursue merger targeting skin diseases Pharmaceutical Technology · Nov 2Jefferson Capital (JCAP) to release Q2 earnings on Aug. 13 GuruFocus.com +2 · Aug 13Virgin Galactic (SPCE) reports $55.9 million loss in Q2 Associated Press +2 · Aug 13
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news